bezafibrate has been researched along with cholecalciferol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Birtwistle, J; Bunce, CM; Davies, NJ; Drayson, MT; Green, RM; Gunther, UL; Hayden, RE; Khanim, FL; Lodi, A; Mountford, JC; Murray, JA; Ride, JP; Schrewe, H; Tiziani, S; Viant, MR | 1 |
2 other study(ies) available for bezafibrate and cholecalciferol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bezafibrate; Cell Differentiation; Cell Line, Tumor; Cholecalciferol; Drug Screening Assays, Antitumor; Glutathione; Humans; Hydroxyprostaglandin Dehydrogenases; I-kappa B Proteins; Leukemia, Myeloid, Acute; Medroxyprogesterone Acetate; PPAR gamma; Prostaglandin D2; Reactive Oxygen Species; Vitamin A | 2009 |